secwatch.observer — SEC 8-K summary
======================================

Issuer:     Omada Health, Inc. (OMDA)
CIK:        0001611115
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001628280-25-050158
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Omada Health Q3 revenue $68M (+49% YoY); first positive adjusted EBITDA $2M
---------------------------------------------------------------------------

- Revenue $68M, up 49% YoY; members 831K, up 53% YoY.
- Net loss $3M vs $9M loss prior year; first quarter of positive adjusted EBITDA of $2M.
- Gross margin 66% (non-GAAP 68%), up from 63% (65%) in Q3 2024.
- Announced new GLP-1 prescribing offering combining behavior change with anti-obesity medications.
- Cash and equivalents $199M at quarter end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1611115/000162828025050158/0001628280-25-050158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1611115/000162828025050158/omda-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-050158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer